

Author: Ivanova L. Kanorskii S. Rostovtseva O. Sufian Basit Galenko-Yaroshevskii P.
Publisher: Springer Publishing Company
ISSN: 0007-4888
Source: Bulletin of Experimental Biology and Medicine, Vol.138, Iss.3, 2004-09, pp. : 301-304
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Long-term oral treatment of patients with acute coronary syndromes and type 2 diabetes mellitus with β-adrenoblockers and angiotensin-converting enzyme inhibitors is associated with positive, though ambiguous changes in the left-ventricular structure and function. These changes should be the reason for choosing optimal therapy ensuring better prognosis in this patient population.
Related content


By Fedorov V. Sal’nikov E. Sidorov A. Bogatushin A. Fateev M.
Bulletin of Experimental Biology and Medicine, Vol. 141, Iss. 1, 2006-01 ,pp. :




The Acer gene of Drosophila codes for an angiotensin-converting enzyme homologue
By Taylor C.A.M. Coates D. Shirras A.D.
Gene, Vol. 181, Iss. 1, 1996-11 ,pp. :

